Skip to main content
  • Policy
    Get Involved
    Join BIOAction
    View Advocacy Toolkit
    Patient Advocacy
    Human Health
    Cost and Value of Biopharmaceuticals
    Antimicrobial Resistance
    Vaccines & Biodefense
    Drug Development & Review
    International
    Global Markets & Trade
    Multilateral Organizations
    Intellectual Property
    All Policy
    Patient Advocacy

    Join BIO as we champion for bringing new treatments to patients with serious medical conditions and to support policies that promote innovation and improve patient access.

  • Member
    Membership Options
    Become a BIO Member
    Member Directory
    Have a Voice
    Membership Eligibility
    Member Toolkit
    Benefits By Sector
    member health
    Human Health
    member startups
    Startups
    member non R&D
    Non-R&D Companies
    Member Savings
    BBS-Programs-vwr
    VWR, Part of Avantor
    75% off Lab Supplies
    Save with BIO
    Save with BIO
  • News & Insights
    Latest biotech news
    Popular blogs
    Events
    Policy
    BIO Statements
    Press Releases
    Letters, Testimony & Comments
    Amicus Briefs
    BIO Reports
    Industry Analysis Reports
    Biotech Jobs
    Economic Development Best Practices
    BIO Briefly
    Issue Briefs
    BIO.News
    I am BIO Podcast
    All News & Insights

    Sign up for the BIO.News Newsletter >

  • Events
    Event Portfolio
    Business Development
    Health
    International
    Professional Development
    Members Only
    All Events
    BIO International Convention

    June 22-25, 2026 | San Diego, CA

    Learn More
    BIO Asia-Taiwan
    BIO Europe

    November 3-5, 2025
    Vienna, Austria

    BIO Investor Forum
    Partnering @JPM Week

    January 12-15, 2026
    San Francisco, CA

    BIO Patient & Health Advocacy Summit
    BIO Investment & Growth Summit

    March 2-3, 2026
    Miami, FL

    BIO Webinars

    Explore the webinar opportunities for interactive, online learning about emerging issues in biotechnology public policy, scientific progress, and raising capital, plus methods to benefit from BIO’s membership services.

  • About
    About Us
    Learn about our priorities
    BIO Leadership
    Meet BIO's Senior Leadership and Board of Directors
    Biotech Basics
    Read about biotechnology
    Industry Recognition
    Get to know the outstanding people and companies BIO supports
    Careers @ BIO
    Explore job openings with BIO today
    Diversity & Inclusion >

    Our tools and initiatives on workforce development, diversity and inclusion are designed to advance a more globally competitive industry.

  • Resource Hub
    Latest Resources
    BIO Early-Stage Resources Hub
    BIO Professional Development
    BIO Content Hub
    Biotech News (BIO.News)
    BIO.News Newsletter
    I am BIO Podcast
    BIO Advocacy Toolkit
    Resources Hub
    BIO Early-Stage Resources Hub
    BIO Professional Development
    BIO Webinars
    BIO Microsites
    Clinical Trials: The Power of Participation
    Covid Vaccine Facts
  • Search Results
    Previously Searched
Logo
Logo
Home
Search
  • Policy
    Human HealthPatient AdvocacyInternationalIntellectual PropertyAll Policies
  • Member
    Become a BIO MemberBenefits By Sector
    Human HealthStartupsNon-R&D Companies
    Member DirectoryHave a VoiceMembership EligibilitySavings
  • News & Insights
    Press ReleasesBio.News BlogLetters, Testimony & CommentsAmicus BriefsIndustry Analysis ReportsBiotech JobsEconomic Development Best PracticesIssue BriefsBIO.NewsVideosAll News & Insights
  • Events
    BIO International ConventionBIO Asia-TaiwanAll Events
  • About
    About UsBIO LeadershipDiversity & InclusionBiotech BasicsIndustry RecognitionCareers @ BIO
  • Resource Hub
    Biotech News (BIO.News)BIO.News NewsletterI am BIO PodcastBIO Advocacy ToolkitBIO Early-Stage Resources HubBIO Professional DevelopmentBIO WebinarsClinical Trials: The Power of ParticipationCovid Vaccine Facts
Search Results
Previously Searched
Search Results
Previously Searched
3124 results found
Expand All
Apply All
3124 results found

Good Day BIO: BARDA funding and animal feed
Share
Good Day BIO Newsletter  •  July 22, 2022
Before the weekend, we have a quick read on why we need to fund BARDA and what the FDA Commissioner said about animal feed. (538 words, 2 minutes, 41 seconds)
Read More

Nebraska Governor Pete Ricketts to Headline BIO’s Impact Ag & Environment Conference in Omaha
Share
Agriculture & Environment  •  Press Release  •  July 21, 2022
BIO is hosting the Impact Ag & Environment Conference, in-person for the first time in three years, in Omaha, Neb., Sept. 19-21, 2022. Headlined by Nebraska Gov. Pete Ricketts, the event will convene leaders across the bioeconomy whose cutting-edge companies are using science to tackle some of our world’s most pressing challenges—from food security to climate, supply chains to energy security, and more. Members of the media are invited to register and attend. What: The BIO Impact Ag & Environment Conference is the premier gathering of global biotech leaders for three days of discussion, partnering and networking to advance the role of science in enhancing agriculture and improving the environment. BIO Communications is available to help with connecting with companies and speakers and setting up interviews. When:  Mon., Sept. 19, – Wed., Sept. 21, 2022   Three plenary sessions, including remarks by Nebraska Gov. Pete Ricketts Local company site tours Over a dozen breakout sessions on growing trust in scientific innovation, expanding the bioeconomy, and mitigating climate change Start-Up Stadium presentations by up-and-coming biotech companies and technologies Exhibit hall featuring the latest technologies and leading companies Where: CHI Health Center, 455 N. 10th St., Omaha, NE 68102 Why: The Impact Ag & Environment Conference is the place to learn more about how today’s biotech innovations are leading to tomorrow’s impact. Click here to register for media credentials.  BIO offers complimentary media registration to editors and reporters working for print, broadcast, or web publications with valid press credentials.
Read More

Good Day BIO: House passes Ag-FDA spending bill that boosts biotech
Share
Good Day BIO Newsletter  •  July 21, 2022
It was a busy Wednesday. The House passed the Ag-FDA spending bill, which boosts biotech and innovation. Two U.S. Senators (and Dr. Michelle) discussed how and why we need to tackle antimicrobial resistance. Plus, BIO responded to the Berlin Declaration on vaccine access. (764 words, 3 minutes, 49 seconds)
Read More

Berlin Declaration will "save lives" in the future
Share
Press Release  •  July 20, 2022
The International Federation of Pharmaceutical Manufacturers & Associations (IFPMA) this week released the “Berlin Declaration” — a framework to work with G7 and G20 on a joint solution for better access to vaccines and treatments around the world for future pandemics. In support of the declaration, BIO president and CEO, Dr. Michelle McMurry-Heath, made the following remarks: “Scientists played a critical role in saving lives over the last two years by developing lifesaving vaccines and therapeutics to combat Covid-19.  “Unfortunately, we know Covid will not be our last pandemic. What we do today will impact how quickly we can defeat the next health crisis.  “The Berlin Declaration outlines ways to allow governments, industry, scientists, and key stakeholders to act quickly in the wake of health crises. Adopting these principles now will no doubt save lives in the future — especially those in underserved areas of the world — by ensuring quick and equitable distribution of innovative vaccines and therapeutics.”  
Read More

Recently Passed House Appropriations Bill Will Spur Agricultural Innovation
Share
Press Release  •  July 20, 2022
Washington, D.C. (July 20, 2022) – John Murphy, chief policy officer for the Biotechnology Innovation Organization, released the following statement in response to the U.S. House of Representatives’ passing the fiscal 2023 Agriculture, Rural Development, Food & Drug Administration and Related Agencies appropriations bill.   “The bill passed by the House supports the innovation needed to secure the food supply and advance sustainable technologies that enable farmers and ranchers to help fight climate change. BIO applauds and thanks members of Congress who voted in favor of this vital funding bill.   “We commend the leadership of Reps. Jimmy Panetta (D-Calif.) and Jim Baird (R-Ind.), and the 19 cosponsors, on the adoption of their amendment to support regulatory consistency by providing FDA the resources it needs to issue guidance on new plant varieties produced using the tools of genome editing and modernize the agency’s plant biotech consultation program. Clear, science-based and timely regulation of agricultural biotech traits is essential to the development and commercialization of critical agricultural biotechnology products in order to facilitate grower access to innovative tools for meeting the challenges facing farmers today and into the future.     We also welcome the adoption of Rep. Baird’s bipartisan amendment to streamline FDA’s review and approval of animal food ingredients, such as feed additives that reduce methane in cattle and enzymes that enhance the digestibility of energy, protein and phosphorus in livestock.   “BIO also thanks the House for including provisions that 1) urge USDA’s Animal and Plant Health Inspection Service to take measurable steps to establish a predictable, science-based regulatory pathway on genetically engineered microbes, 2) encourage the National Institute of Food and Agriculture to support non-profit ag biotech research partners to engage in transgenic plant research, and 3) provide $16…
Read More

Good Day BIO: Drug prices drop or rise only slightly, says MedPAC
Share
Good Day BIO Newsletter  •  July 20, 2022
With the Senate considering drug price controls, Congress’s MedPAC finds prices fell for many drugs that would be subject to price setting. Plus, BIO IMPACT returns to an in-person event in September—here’s why it’s so timely. (750 words, 3 minutes, 45 seconds)
Read More

Good Day BIO: Drug prices rising more slowly than inflation – plus, base editing makes its debut
Share
Good Day BIO Newsletter  •  July 19, 2022
The latest data shows drug prices are still rising slower than inflation—so, why are drug manufacturers the target when it comes to controlling health care costs? Plus, a BIO member company launched the first human trial of “base editing,” which could be a game-changer for patients and the potential of gene editing. (667 words, 3 minutes, 20 seconds)
Read More

Good Day BIO: Childhood vaccinations see largest drop in 30 years
Share
Good Day BIO Newsletter  •  July 18, 2022
Childhood vaccinations dropped in every region in 2021, says new WHO/UNICEF data—here’s what happened and what we can do about it. Plus, BIO’s Dr. Michelle McMurry-Heath explains how biotech can address America’s nutritional gaps. (638 words, 3 minutes, 11 secondsP.S. It’s not too late to register for BIO Asia-Taiwan, happening July 27-31 both in Taipei and online—but hurry, because pre-registration closes on Wednesday, July 20! Get more details and register now.
Read More

Accelerated Approval Pathway Resources
Share
Policy

BIO Statement for House Select Committee on the Climate Crisis Hearing
Share
Letters, Testimony & Comments  •  July 15, 2022
BIO submitted a statement for the record to the U.S. House of Representatives Select Committee on the Climate Crisis for the committee's hearing titled "Climate Smart From Farm to Fork: Building an Affordable and Resilient Food Supply Chain." BIO's statement supports adoption of innovative, sustainable technologies and practices and expedited regulatory pathways for breakthrough technology solutions.
Read More

Pagination

  • First First page
  • Prev Previous page
  • …
  • 134
  • 135
  • 136
  • …
  • Next Next page
  • Last Last page
Biotechnology Innovation Organization
Explore BIO
Policy
Events
About
Industry Insights
Join Now
BIO PAC
For Members
Member Directory
BIO Policy Committees
Cost-Savings Program
BIO Events
BIO International Convention
BIO Partnering at JPM Week
BIO CEO & Investor Conference
BIO Investor Forum
BIO Patient Health & Advocacy Summit
BIO Intellectual Property Counsels Committee Conference
1201 New York Avenue NW, Suite 1300, Washington, DC, 20005 ・ 202-962-9200
© BIO 2025 All Rights Reserved
Privacy Policy
Terms of Use
Contact BIO